Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Novartis (NVS) and Eli Lilly (LLY). But which of these two stocks is more attractive to value ...
Amgen Inc.'s Q3 earnings may not be a major upside, but new pipeline drugs and potential breakthroughs could drive growth.
PSI Advisors LLC lifted its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 0.4% during the third quarter, ...
Grassi Investment Management lessened its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 0.2% in the ...
New results show Eli Lilly’s Ebglyss improved skin and itch among patients with moderate-to-severe atopic dermatitis who were previously treated with dupilumab. These results fr ...
Citi raised the firm’s price target on Eli Lilly (LLY) to $1,250 from $1,060 and keeps a Buy rating on the shares following a transfer of ...
Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
Eli Lilly and Company has shown rapid growth with significant revenue increases. Click here to find out why I've decided to ...
Lilium’s stock nosedives over 55% as two key subsidiaries face insolvency. The aerospace startup struggles to secure state ...